ISCTR (International Society for Cardiovascular Translational Research) is a renowned organization dedicated to expediting the discovery and application of innovative therapies for cardiovascular diseases. With a mission to save lives and decrease costs, ISCTR collaborates with leading universities, clinical and basic scientists, industry representatives, regulatory agencies, and patients to foster multi-disciplinary collaboration in the field of cardiovascular devices. Through their online courses, annual summits, and publications like the Journal of Cardiovascular Translational Research, ISCTR aims to optimize patient care and make a difference in the field of cardiovascular medicine.
ISCTR's Translational Pathways for Cardiovascular Devices program brings together a network of experts, including renowned physicians and industry leaders, to provide comprehensive text and lectures on the latest advancements in cardiovascular device research. Their commitment to collaboration and innovation is evident in the testimonials from esteemed individuals such as Dr. Spencer B. King III and Dr. Stanton J. Rowe. Additionally, ISCTR's Patients Voice Program empowers cardiovascular patients to contribute their opinions and shape guideline recommendations and product approvals, ultimately improving patient care and outcomes.
Generated from the website